Disease | hemolytic-uremic syndrome |
Comorbidity | C0018801|heart failure |
Sentences | 2 |
PubMedID- 24403266 | Of the nine treatment-related events, one was reported by the investigator as tigatuzumab related (peripheral edema) and the other eight were considered by investigators as possibly related to gemcitabine (pleural effusion, urinary tract infection, pneumonia, anemia [two patients], hemolytic uremic syndrome with bowel perforation, heart failure, and vomiting). |
PubMedID- 26557394 | Acute systolic heart failure associated with complement-mediated hemolytic uremic syndrome. |
Page: 1